Join us as at the scientific presentation of our novel cancer immunotherapy discovery at the 2022 ESMO Congress in Paris, France.

Meet the Innovimmune team at the 2022 BIO Asia-Taiwan Meeting in Taipei.

Meet the Innovimmune team at the 2022 BIO Meeting in San Diego, CA, USA.

Join us as at the scientific presentation of our novel cancer immunotherapy discovery at the 2022 American Association for Cancer Research Annual Meeting in New Orleans, LA, USA.

Meet with the Innovimmune Team at the ESMO Congress 2020 which will take place from 18 to 22 September 2020, in Madrid, Spain.

Meet with the Innovimmune Team at BIO Asia in Taipei, Taiwan. The BIO Asia–Taiwan 2020 Conference and Exhibition, July 22-26 in Taipei, Taiwan will bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia to meet and explore business opportunities with Taiwan’s emerging biotech sector.

Meet our CEO/CSO Anderson Gaweco at the American Association for Cancer Research 2020 Virtual Meeting II on June 22 - 24, 2020.

Meet with the Innovimmune Team at BIO Digital, a virtual gathering of the global biotech industry. We may not be able to gather in person, but nothing stops innovation.

Join Innovimmune at the COVID-19 Virtual Partnering meeting. We are seeking out-licensing partners for the fast-tracked development of our proprietary INV-88 oral macrophage migration inhibitory factor inhibitors as a novel anti-cytokine-storm targeted therapy for ARDS in COVID-19.

New York Lieutenant Governor Kathy Hochul at the Innovimmune R&D Labs with Dr. Anderson Gaweco, CEO of Innovimmune Biotherapeutics and Dr. Eva Cramer, President, Downstate Biotechnology Park.